NanoVibronix Inc (NAOV):製品パイプライン分析

◆英語タイトル:NanoVibronix Inc (NAOV) - Product Pipeline Analysis, 2017 Update
◆商品コード:DATA8010021
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD1,500 ⇒換算¥222,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥333,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
NanoVibronix Inc (NanoVibronix) is a medical device company that offers therapeutic ultrasound technology solutions. The company offers clinical applications such as catheter related injury and its complications, pain and soft tissue healing. It offers electronic unit that uses disposable patches through that it delivers localized energy creating therapeutics. NanoVibronix also offers medical kits, that are used in preventing catheter related complications. The company’s products offer solutions for relief chronic and acute pain and treatment for trigeminal neuralgia. It operates in the US and Israel. NanoVibronix is headquartered in Elmsford, New York, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company NanoVibronix Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
NanoVibronix Inc Company Overview 4
NanoVibronix Inc Company Snapshot 4
NanoVibronix Inc Pipeline Products and Ongoing Clinical Trials Overview 4
NanoVibronix Inc – Pipeline Analysis Overview 7
NanoVibronix Inc – Key Facts 7
NanoVibronix Inc – Major Products and Services 8
NanoVibronix Inc Pipeline Products by Development Stage 9
NanoVibronix Inc Ongoing Clinical Trials by Trial Status 11
NanoVibronix Inc Pipeline Products Overview 13
LungShield 13
LungShield Product Overview 13
Renooskin 14
Renooskin Product Overview 14
TrachShield 15
TrachShield Product Overview 15
TrachShield Clinical Trial 16
Uroshield 17
Uroshield Product Overview 17
Uroshield Clinical Trial 18
NanoVibronix Inc – Key Competitors 19
NanoVibronix Inc – Key Employees 20
NanoVibronix Inc – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
NanoVibronix Inc, Recent Developments 22
Dec 05, 2017: NanoVibronix Announces Exclusive UK Distributor for PainShield Providing Patients an Alternative to Opioids and Surgery 22
Nov 29, 2017: NanoVibronix Reports Successful Interim Trial Results for Use of PainShield in Patients with Trigeminal Neuralgia; Represents Potential Alternative to Opioid and Surgical Interventions 22
Jul 12, 2017: NanoVibronix Announces Successful Interim Trial Results for UroShield 22
Mar 09, 2017: US Patent and Trademark Office Grants Patent to NanoVibronix for Surface Acoustic Wave Technology 23
Jan 09, 2017: NanoVibronix Announces Abstract Acceptance and Presentation at the European Association of Urology’s 32nd Anniversary EAU Congress 23
Dec 28, 2016: NanoVibronix Receives Health Canada Approval to Sell WoundShield in Canada 24
Nov 15, 2016: NanoVibronix Provides Third Quarter 2016 Business Update 24
Oct 20, 2016: NanoVibronix Expands Senior Management Team and Board of Directors 25
Sep 28, 2016: NanoVibronix Announces Distribution Agreement With Mano Equestrian Services (PTE) LTD in Singapore for Equine PainShield 26
Sep 06, 2016: NanoVibronix Receives Health Canada Approval to Sell UroShield in Canada 26
Appendix 27
Methodology 27
About GlobalData 29
Contact Us 29
Disclaimer 30

List of Tables
NanoVibronix Inc Pipeline Products and Ongoing Clinical Trials Overview 4
NanoVibronix Inc Pipeline Products by Equipment Type 5
NanoVibronix Inc Pipeline Products by Indication 6
NanoVibronix Inc Ongoing Clinical Trials by Trial Status 6
NanoVibronix Inc, Key Facts 7
NanoVibronix Inc, Major Products and Services 8
NanoVibronix Inc Number of Pipeline Products by Development Stage 9
NanoVibronix Inc Pipeline Products Summary by Development Stage 10
NanoVibronix Inc Ongoing Clinical Trials by Trial Status 11
NanoVibronix Inc Ongoing Clinical Trials Summary 12
LungShield - Product Status 13
LungShield - Product Description 13
Renooskin - Product Status 14
Renooskin - Product Description 14
TrachShield - Product Status 15
TrachShield - Product Description 15
TrachShield - TrachShield in Prevention of Bacterial Growth on the Endotracheal Tube 16
Uroshield - Product Status 17
Uroshield - Product Description 17
Uroshield - Does UROSHIELD Influence Bacterial Growth on Endotracheal Tubes 18
Uroshield - The Effect of Surface Acoustic Waves on the Prevention of Bacterial Colonization in Longterm Indwelling Urinary Catheters 18
NanoVibronix Inc, Key Employees 20
NanoVibronix Inc, Subsidiaries 21
Glossary 28

★海外企業調査レポート[NanoVibronix Inc (NAOV):製品パイプライン分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Kingboard Laminates Holdings Limited (1888):企業の財務・戦略的SWOT分析
    Kingboard Laminates Holdings Limited (1888) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …
  • MediciNova Inc (MNOV):製薬・医療:M&Aディール及び事業提携情報
    Summary MediciNova Inc (MediciNova) focuses on acquiring, and developing novel, small-molecule therapeutics for the treatment of neurology, respiratory, and liver diseases. MediciNova’s developmental pipeline includes core programs for the treatment of fibrotic diseases; neurological disorders; and …
  • Gilead Sciences Inc (GILD):企業の財務・戦略的SWOT分析
    Gilead Sciences Inc (GILD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Avacta Group Plc (AVCT)-製薬・医療分野:企業M&A・提携分析
    Summary Avacta Group Plc (Avacta) is a developer therapeutic molecules used in a wide range of life sciences applications in research and diagnostics. The company offers products which include optim and sensipod. It also develops UCB celltech, which is an analytical instrument. Avacta’s sensipod is …
  • Banque Cantonale Vaudoise:企業の戦略・SWOT・財務分析
    Banque Cantonale Vaudoise - Strategy, SWOT and Corporate Finance Report Summary Banque Cantonale Vaudoise - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Anadarko Petroleum Corp (APC):石油・ガス:M&Aディール及び事業提携情報
    Summary Anadarko Petroleum Corp (Anadarko) is an independent upstream oil and gas company, which carries out exploration, development, production, and marketing of natural gas, crude oil, condensate, and natural gas liquids (NGLs) from its assets. It also involves in gathering, processing, treating, …
  • Companhia Energetica de Minas Gerais SA (CMIG4):企業の財務・戦略的SWOT分析
    Companhia Energetica de Minas Gerais SA (CMIG4) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key st …
  • Tokyo Broadcasting System Holdings, Inc. (9401):企業の財務・戦略的SWOT分析
    Tokyo Broadcasting System Holdings, Inc. (9401) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key st …
  • Meridian Bioscience Inc (VIVO):企業の財務・戦略的SWOT分析
    Meridian Bioscience Inc (VIVO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Net One Systems Co Ltd (7518):企業の財務・戦略的SWOT分析
    Net One Systems Co Ltd (7518) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • BAM Nuttall Ltd:企業の戦略的SWOT分析
    BAM Nuttall Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Vortex Energy Holding AG:電力:M&Aディール及び事業提携情報
    Summary Vortex Energy Holding AG (Vortex Energy) is a provider of renewable energy services. The company's services include development, consulting, financing, planning, implementation, construction, technical management, technical inspection, commercial management, and energy trading services. It a …
  • Credit Suisse (UK) Private Banking:企業の戦略・SWOT・財務情報
    Credit Suisse (UK) Private Banking - Strategy, SWOT and Corporate Finance Report Summary Credit Suisse (UK) Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • L-3 Communications Oceania Limited:企業の戦略・SWOT・財務情報
    L-3 Communications Oceania Limited - Strategy, SWOT and Corporate Finance Report Summary L-3 Communications Oceania Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Ferring International Center SA:企業の戦略的SWOT分析
    Ferring International Center SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Continental Grain Co:企業の戦略的SWOT分析
    Continental Grain Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Humana Inc.:企業の戦略・SWOT・財務分析
    Humana Inc. - Strategy, SWOT and Corporate Finance Report Summary Humana Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Ameren Corporation:企業の戦略・SWOT・財務情報
    Ameren Corporation - Strategy, SWOT and Corporate Finance Report Summary Ameren Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • RegeneRx Biopharmaceuticals Inc (RGRX):企業の財務・戦略的SWOT分析
    Summary RegeneRx Biopharmaceuticals Inc (RegeneRx) is a clinical-stage biopharmaceutical company that designs, researches and develops novel peptides targeted at diseases with unmet medical needs. The company offers clinical trials, science and discovery and business development services. Its busine …
  • Step Pharma SAS-製薬・医療分野:企業M&A・提携分析
    Summary Step Pharma SAS (Step Pharma) is a biotechnology company, which strives to discover and develop proprietary small molecule medicines for the treatment of auto-immune diseases. The company is developing a new class of oral nucleotide synthesis inhibitors against cytidine triphosphate synthase …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆